Health In Tech Q2 2026 revenue down 13% to $8.1M; net loss $2.5M vs prior-year income

Health In Tech, Inc.

2026-Q2 EPS reported -$0.07 revenue$16,828,266

Q2 2026 revenue $8.1M vs $9.3M in Q2 2025; net loss $2.5M ($0.04/share) vs net income $0.6M ($0.01/share).
Adjusted EBITDA -$1.3M in Q2 2026; first-half 2026 revenue $16.8M vs $17.3M prior year.
Contracted revenue $32.3M as of June 30, 2026; pipeline revenue $66.3M as of July 31, 2026.
Distribution partners 933, up 19.9% YoY; reaffirms FY2026 revenue guidance of $45-50M.
Secured first employer group for Three-Year Rate Stabilization Program; HitRix launch expected H2 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.